MARIA LE MOND: Open Payments
NPI 1477245769 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,149 in 34 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $319 · 2025 $1,149
Food & beverage: $1,149
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $389 |
| AstraZeneca Pharmaceuticals LP | 3 | $261 |
| Amgen Inc. | 4 | $192 |
| Exact Sciences Corporation | 5 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| Lilly USA, LLC | 2 | $36 |
| Edwards Lifesciences Corporation | 1 | $22 |
| Boston Scientific Corporation | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: Ozempic, REPATHA, AIRSUPRA, BREZTRI, Cologuard Collection Kit, JARDIANCE, MOUNJARO, Rybelsus.
Industry payments across TX — which companies pay providers there.
